GetTopicDetailResponse(id=0c3d5e2871, topicName=Dayvigo, introduction=Dayvigo, content=null, image=null, comments=4, allHits=1298, url=https://h5.medsci.cn/topic?id=5728, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=98111, tagList=[TagDto(tagId=98111, tagName=Dayvigo)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=1643062, encodeId=c37e164306233, content=<a href='/topic/show?id=0c3d5e2871' target=_blank style='color:#2F92EE;'>#Dayvigo#</a>, objectTitle=衛(wèi)材在日本推出新型抗失眠藥Dayvigo（lemborexant）, objectType=article, longId=197186, objectId=ec5319e186eb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ec5319e186eb, replyNumber=0, likeNumber=92, createdTime=2021-03-27, rootId=0, userName=bshuang, userId=d1e223091112, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ec5319e186eb, moduleTitle=衛(wèi)材在日本推出新型抗失眠藥Dayvigo（lemborexant）, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=ec5319e186eb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1643063, encodeId=546d16430639a, content=<a href='/topic/show?id=0c3d5e2871' target=_blank style='color:#2F92EE;'>#Dayvigo#</a>, objectTitle=SLEEP 2020：DAYVIGO（lemborexant）治療成年失眠，III期臨床確認(rèn)了其有效性和安全性, objectType=article, longId=200038, objectId=5362200038e5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5362200038e5, replyNumber=0, likeNumber=156, createdTime=2021-06-05, rootId=0, userName=bshuang, userId=d1e223091112, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5362200038e5, moduleTitle=SLEEP 2020：DAYVIGO（lemborexant）治療成年失眠，III期臨床確認(rèn)了其有效性和安全性, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=5362200038e5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1643060, encodeId=3f99164306010, content=<a href='/topic/show?id=0c3d5e2871' target=_blank style='color:#2F92EE;'>#Dayvigo#</a>, objectTitle=失眠癥治療迎來曙光：FDA已批準(zhǔn)衛(wèi)材的Dayvigo, objectType=article, longId=185145, objectId=26df1851459f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=26df1851459f, replyNumber=0, likeNumber=84, createdTime=2020-08-01, rootId=0, userName=bshuang, userId=d1e223091112, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=26df1851459f, moduleTitle=失眠癥治療迎來曙光：FDA已批準(zhǔn)衛(wèi)材的Dayvigo, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=26df1851459f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1643061, encodeId=5810164306198, content=<a href='/topic/show?id=0c3d5e2871' target=_blank style='color:#2F92EE;'>#Dayvigo#</a>, objectTitle=JAMA Network Open：DAYVIGO（lemborexant）治療失眠癥的關(guān)鍵III期研究, objectType=article, longId=185379, objectId=6b761853e9f9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6b761853e9f9, replyNumber=0, likeNumber=0, createdTime=2020-07-26, rootId=0, userName=bshuang, userId=d1e223091112, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6b761853e9f9, moduleTitle=JAMA Network Open：DAYVIGO（lemborexant）治療失眠癥的關(guān)鍵III期研究, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=6b761853e9f9)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
